Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

A potential role for crystallization inhibitors in treatment of Alzheimer's disease.

Grases F, Costa-Bauzà A, Prieto RM.

Med Hypotheses. 2010 Jan;74(1):118-9. doi: 10.1016/j.mehy.2009.07.029. Epub 2009 Aug 8.

PMID:
19666212
2.

Role of melatonin in Alzheimer-like neurodegeneration.

Wang JZ, Wang ZF.

Acta Pharmacol Sin. 2006 Jan;27(1):41-9. Review.

3.

Non-cholinergic strategies for treating and preventing Alzheimer's disease.

Doraiswamy PM.

CNS Drugs. 2002;16(12):811-24. Review.

PMID:
12421115
4.

Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties.

Fernández-Bachiller MI, Pérez C, Campillo NE, Páez JA, González-Muñoz GC, Usán P, García-Palomero E, López MG, Villarroya M, García AG, Martínez A, Rodríguez-Franco MI.

ChemMedChem. 2009 May;4(5):828-41. doi: 10.1002/cmdc.200800414.

PMID:
19308922
5.

Melatonin acts as antioxidant and pro-oxidant in an organotypic slice culture model of Alzheimer's disease.

Clapp-Lilly KL, Smith MA, Perry G, Harris PL, Zhu X, Duffy LK.

Neuroreport. 2001 May 8;12(6):1277-80.

PMID:
11338206
6.

The neuroprotective activities of melatonin against the Alzheimer beta-protein are not mediated by melatonin membrane receptors.

Pappolla MA, Simovich MJ, Bryant-Thomas T, Chyan YJ, Poeggeler B, Dubocovich M, Bick R, Perry G, Cruz-Sanchez F, Smith MA.

J Pineal Res. 2002 Apr;32(3):135-42.

PMID:
12074096
7.

Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease.

Behl C.

Cell Tissue Res. 1997 Dec;290(3):471-80. Review.

PMID:
9369525
8.

The neuroprotective role of melatonin against amyloid beta peptide injected mice.

Masilamoni JG, Jesudason EP, Dhandayuthapani S, Ashok BS, Vignesh S, Jebaraj WC, Paul SF, Jayakumar R.

Free Radic Res. 2008 Jul;42(7):661-73. doi: 10.1080/10715760802277388.

PMID:
18654881
9.

The human pineal gland and melatonin in aging and Alzheimer's disease.

Wu YH, Swaab DF.

J Pineal Res. 2005 Apr;38(3):145-52. Review.

PMID:
15725334
10.

Effect of melatonin on changes in locomotor activity rhythm of Syrian hamsters injected with beta amyloid peptide 25-35 in the suprachiasmatic nuclei.

Furio AM, Cutrera RA, Castillo Thea V, Pérez Lloret S, Riccio P, Caccuri RL, Brusco LL, Cardinali DP.

Cell Mol Neurobiol. 2002 Dec;22(5-6):699-709.

PMID:
12585689
11.

Melatonin reduces interleukin secretion in amyloid-beta stressed mouse brain slices.

Clapp-Lilly KL, Smith MA, Perry G, Duffy LK.

Chem Biol Interact. 2001 Mar 14;134(1):101-7.

PMID:
11248225
12.

Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide.

Pappolla MA, Sos M, Omar RA, Bick RJ, Hickson-Bick DL, Reiter RJ, Efthimiopoulos S, Robakis NK.

J Neurosci. 1997 Mar 1;17(5):1683-90.

13.

Melatonin protects SHSY5Y neuroblastoma cells from cobalt-induced oxidative stress, neurotoxicity and increased beta-amyloid secretion.

Olivieri G, Hess C, Savaskan E, Ly C, Meier F, Baysang G, Brockhaus M, Müller-Spahn F.

J Pineal Res. 2001 Nov;31(4):320-5.

PMID:
11703561
14.

Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid.

Chyan YJ, Poeggeler B, Omar RA, Chain DG, Frangione B, Ghiso J, Pappolla MA.

J Biol Chem. 1999 Jul 30;274(31):21937-42.

15.

Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease.

Brunner P, Sözer-Topcular N, Jockers R, Ravid R, Angeloni D, Fraschini F, Eckert A, Müller-Spahn F, Savaskan E.

Eur J Histochem. 2006 Oct-Dec;50(4):311-6.

PMID:
17213040
16.

Inhibition of Alzheimer beta-fibrillogenesis by melatonin.

Pappolla M, Bozner P, Soto C, Shao H, Robakis NK, Zagorski M, Frangione B, Ghiso J.

J Biol Chem. 1998 Mar 27;273(13):7185-8.

17.

Melatonin reduces amyloid beta-induced apoptosis in pheochromocytoma (PC12) cells.

Feng Z, Zhang JT.

J Pineal Res. 2004 Nov;37(4):257-66.

PMID:
15485552
18.

Pineal calcification in Alzheimer's disease: an in vivo study using computed tomography.

Mahlberg R, Walther S, Kalus P, Bohner G, Haedel S, Reischies FM, Kühl KP, Hellweg R, Kunz D.

Neurobiol Aging. 2008 Feb;29(2):203-9. Epub 2006 Nov 13.

PMID:
17097768
19.

Role of melatonin in neurodegenerative diseases.

Srinivasan V, Pandi-Perumal SR, Maestroni GJ, Esquifino AI, Hardeland R, Cardinali DP.

Neurotox Res. 2005;7(4):293-318. Review.

PMID:
16179266
20.

Beneficial effects of melatonin in experimental models of Alzheimer disease.

Cheng Y, Feng Z, Zhang QZ, Zhang JT.

Acta Pharmacol Sin. 2006 Feb;27(2):129-39. Review.

Items per page

Supplemental Content

Write to the Help Desk